Related references
Note: Only part of the references are listed.IL-10: The master regulator of immunity to infection
Kevin N. Couper et al.
JOURNAL OF IMMUNOLOGY (2008)
Host defense peptide LL-37, in synergy with inflammatory mediator IL-1β, augments immune responses by multiple pathways
Jie Yu et al.
JOURNAL OF IMMUNOLOGY (2007)
An antimicrobial cathelicidin peptide, human CAP18/LL-37, suppresses neutrophil apoptosis via the activation of formyl-peptide receptor-like 1 and P2X7
Isao Nagaoka et al.
JOURNAL OF IMMUNOLOGY (2006)
Modulation of the TLR-mediated inflammatory response by the endogenous human host defense peptide LL-37
N Mookherjee et al.
JOURNAL OF IMMUNOLOGY (2006)
Structure-function relationships among human cathelicidin peptides: Dissociation of antimicrobial properties from host immunostimulatory activities
MH Braff et al.
JOURNAL OF IMMUNOLOGY (2005)
The human cationic peptide LL-37 induces activation of the extracellular signal-regulated kinase and p38 kinase pathways in primary human monocytes
DME Bowdish et al.
JOURNAL OF IMMUNOLOGY (2004)
The cationic antimicrobial peptide LL-37 modulates dendritic cell differentiation and dendritic cell-induced T cell polarization
DJ Davidson et al.
JOURNAL OF IMMUNOLOGY (2004)
The antimicrobial peptide LL-37 activates innate immunity at the airway epithelial surface by transactivation of the epidermal growth factor receptor
GS Tjabringa et al.
JOURNAL OF IMMUNOLOGY (2003)
Increased levels of antimicrobial peptides in tracheal aspirates of newborn infants during infection
S Schaller-Bals et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2002)
IL-10 gene expression is controlled by the transcription factors Sp1 and Sp3
M Tone et al.
JOURNAL OF IMMUNOLOGY (2000)
Share Paper
